Conclusions Subclinical studies and epidemiological observational studies indicated that exposure to dioxins as persistent endocrine-disrupting chemicals is a cause of metabolic dysfunction associated with steatotic liver disease, as evidenced by hepatic steatosis and the presence of obesity, type 2 diabetes, and abnormal lipid profiles, which is due to the activation of hepatic aryl hydrocarbon receptor
Conclusion While semaglutide (Ozempic and Wegovy) is an effective weight loss treatment, it can have some oral health side effects such as dry mouth, nausea, and dietary changes
These are groups where pre-asthma could possibly be identified using cohort studies and sensitive airway assays, such as FeNO, sputum eosinophils or bronchial hyper-reactivity
The NLPR3 inflammasome and obesity-related kidney disease
Might that be a GLP-1 effect